- Home
- IBRX vs GOGO Comparison
IBRX vs GOGO Comparison
Compare IBRX & GOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBRX
- GOGO
- Stock Information
- Founded
- IBRX 2014
- GOGO 1991
- Country
- IBRX United States
- GOGO United States
- Employees
- IBRX N/A
- GOGO N/A
- Industry
- IBRX Biotechnology: Biological Products (No Diagnostic Substances)
- GOGO Telecommunications Equipment
- Sector
- IBRX Health Care
- GOGO Consumer Discretionary
- Exchange
- IBRX Nasdaq
- GOGO Nasdaq
- Market Cap
- IBRX 2.3B
- GOGO 2.2B
- IPO Year
- IBRX N/A
- GOGO 2013
- Fundamental
- Price
- IBRX $2.58
- GOGO $9.44
- Analyst Decision
- IBRX Strong Buy
- GOGO Buy
- Analyst Count
- IBRX 6
- GOGO 2
- Target Price
- IBRX $9.83
- GOGO $14.00
- AVG Volume (30 Days)
- IBRX 9.7M
- GOGO 1.4M
- Earning Date
- IBRX 11-10-2025
- GOGO 11-06-2025
- Dividend Yield
- IBRX N/A
- GOGO N/A
- EPS Growth
- IBRX N/A
- GOGO N/A
- EPS
- IBRX N/A
- GOGO 0.04
- Revenue
- IBRX $56,600,000.00
- GOGO $694,673,000.00
- Revenue This Year
- IBRX $629.94
- GOGO $107.81
- Revenue Next Year
- IBRX $109.91
- GOGO $3.12
- P/E Ratio
- IBRX N/A
- GOGO $212.79
- Revenue Growth
- IBRX 4227.22
- GOGO 72.74
- 52 Week Low
- IBRX $1.83
- GOGO $6.20
- 52 Week High
- IBRX $6.82
- GOGO $16.82
- Technical
- Relative Strength Index (RSI)
- IBRX 54.54
- GOGO 50.41
- Support Level
- IBRX $2.30
- GOGO $9.05
- Resistance Level
- IBRX $2.67
- GOGO $9.93
- Average True Range (ATR)
- IBRX 0.12
- GOGO 0.49
- MACD
- IBRX 0.01
- GOGO 0.13
- Stochastic Oscillator
- IBRX 75.68
- GOGO 60.48
About IBRX ImmunityBio Inc.
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its platforms for the development of biologic product candidates include (i) antibody-cytokine fusion proteins, (ii) DNA, RNA, and recombinant protein vaccines, and (iii) cell therapies. Its focus includes bladder, lung, and colorectal cancers and GBM and its product candidate Anktiva is an IL-15 superagonist antibody-cytokine fusion protein. It has two geographical segments: the United States and Europe. Key revenue is generated from the United States.
About GOGO Gogo Inc.
Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. Its business segment includes Gogo BA and Satcom Direct. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped.